5De Luca G, Stone GW, Suryapranata H, et al. Efficacy and safety of drug-eluting stents in ST-sement elevation nay ocardial intarction: A meta analysis of randomized trials [ J ]. Int J Cardiol, 2009,133 ( 2 ) : 213 -222.
2Moses JW,Leon MB,Popma JJ,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003,349:1315-1323.
3Stone GW,Ellis SG,Cox DA,et al. A polymer-based,paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med, 2004,350:221-231.
4Marxs O, Marxs AR. Bench to bedside : the development of rapamycin and its application to stent restenosis. Circulation, 2001, 104:852-855.
5LEE T T, FEINBERG L, BAIM D S,et al. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials)[J]. Am J Cardiol, 2006, 98:718--721.
6KIRTANE A J, ELLIS S G, DAWKINS K D,et al.Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials[J]. J Am Coll Cardiol, 2008, 51:708--715.
7CAMPEAU L. Letter: Grading of angina pectoris [J]. Circulation, 1976, 54 : 522--523.
8HAMM C W, BRAUNWALD E. A classification of unstabte angina revisited[J]. Circulation, 2000, 102 :118--122.
9HIGGINS J P, THOMPSON S G. Quantifying heterogeneity in a meta-analysis[J]. Star Med, 2002,21. 1539-1558.
10MARESTA A, VARANI E, BALDUCELLI M, et al. Comparison of effectiveness and safety of sirolimus-eluting stents versus Bare-Metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study) [J]. Am J Cardiol, 2008, 101:1560--1566.
